Efficacy and Safety of Mirikizumab (LY3074828) in a Phase 2 Study of Patients with Crohn's Disease

Bruce E. Sands  1     William Sandborn  2     Laurent Peyrin-Biroulet  3     Peter Higgins  4     Fumihito Hirai  5     Ruth Belin  6     Elisa Gomez Valderas  7     Debra Miller     MaryAnn Morgan-Cox     April Naegeli     Paul Pollack     Jay Tuttle     Toshifumi Hibi    
1 Mount Sinai Hospital,New York,United States
2 University California San Diego,La Jolla,United States
3 Nancy University Hospital,Vandoeuvre-les-Nancy,France
4 Michigan Medicine Gastroenterology Clinic,Ann Arbor,United States
5 Fukuoka University,Fukuoka,Japan
6 Eli Lilly & Company,Indianapolis,United States
7 Eli Lilly & Company,In

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing